These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Microarray analysis identifies an aberrant expression of apoptosis and DNA damage-regulatory genes in multiple sclerosis. Satoh J; Nakanishi M; Koike F; Miyake S; Yamamoto T; Kawai M; Kikuchi S; Nomura K; Yokoyama K; Ota K; Kanda T; Fukazawa T; Yamamura T Neurobiol Dis; 2005 Apr; 18(3):537-50. PubMed ID: 15755681 [TBL] [Abstract][Full Text] [Related]
4. Genomic effects of once-weekly, intramuscular interferon-beta1a treatment after the first dose and on chronic dosing: Relationships to 5-year clinical outcomes in multiple sclerosis patients. Weinstock-Guttman B; Bhasi K; Badgett D; Tamaño-Blanco M; Minhas M; Feichter J; Patrick K; Munschauer F; Bakshi R; Ramanathan M J Neuroimmunol; 2008 Dec; 205(1-2):113-25. PubMed ID: 18950872 [TBL] [Abstract][Full Text] [Related]
5. Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to disease. Bomprezzi R; Ringnér M; Kim S; Bittner ML; Khan J; Chen Y; Elkahloun A; Yu A; Bielekova B; Meltzer PS; Martin R; McFarland HF; Trent JM Hum Mol Genet; 2003 Sep; 12(17):2191-9. PubMed ID: 12915464 [TBL] [Abstract][Full Text] [Related]
6. Absence of MxA induction by interferon beta in patients with MS reflects complete loss of bioactivity. Hesse D; Sellebjerg F; Sorensen PS Neurology; 2009 Aug; 73(5):372-7. PubMed ID: 19652141 [TBL] [Abstract][Full Text] [Related]
7. Gene expression changes in peripheral blood mononuclear cells from multiple sclerosis patients undergoing beta-interferon therapy. Singh MK; Scott TF; LaFramboise WA; Hu FZ; Post JC; Ehrlich GD J Neurol Sci; 2007 Jul; 258(1-2):52-9. PubMed ID: 17467740 [TBL] [Abstract][Full Text] [Related]
8. Blood transcriptional signatures of multiple sclerosis: unique gene expression of disease activity. Achiron A; Gurevich M; Friedman N; Kaminski N; Mandel M Ann Neurol; 2004 Mar; 55(3):410-7. PubMed ID: 14991819 [TBL] [Abstract][Full Text] [Related]
9. Gene expression profiling of relevant biomarkers for treatment evaluation in multiple sclerosis. Hong J; Zang YC; Hutton G; Rivera VM; Zhang JZ J Neuroimmunol; 2004 Jul; 152(1-2):126-39. PubMed ID: 15223245 [TBL] [Abstract][Full Text] [Related]
10. Implication of the Toll-like receptor 4 pathway in the response to interferon-β in multiple sclerosis. Bustamante MF; Fissolo N; Río J; Espejo C; Costa C; Mansilla MJ; Lizasoain I; Moro MA; Carmen Edo M; Montalban X; Comabella M Ann Neurol; 2011 Oct; 70(4):634-45. PubMed ID: 22028223 [TBL] [Abstract][Full Text] [Related]